2020
DOI: 10.21203/rs.3.rs-120537/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Fractional CO2 laser combined with 595-nm PDL inhibiting hypertrophic scars via measuring BMP-7 and Fas expression in rabbit models

Abstract: Background and ObjectivesAlthough the treatment of hypertrophic scar (HS) remain challenging, fractional CO2 laser (FCO2L) and 595-nm pulsed-dye laser (PDL) have proved clinical efficacy. Meanwhile, BMP-7 and Fas proteins are demonstrated to promote wound healing and inhibit scar formation, yet few reports on the effect of the two proteins on hypertrophic scarring are available, and their molecular mechanisms remain unclear. In current study, we attempted to observe the effect of combined use of FCO2L with 595… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 43 publications
(144 reference statements)
0
1
0
Order By: Relevance
“…The combined use of ablative CO 2 and dye laser therapy offers a novel, promising approach for the treatment of ear keloids. Ablative CO 2 laser therapy is known for its ability to effectively resurface the skin and improve keloid texture by promoting collagen remodeling [2]. In the present study, we meticulously detail our institution's robust clinical experience harnessing this innovative, dual-modality treatment regimen, aiming to meticulously refine ear keloid morphology and enhance its tactile quality.…”
Section: Introductionmentioning
confidence: 99%
“…The combined use of ablative CO 2 and dye laser therapy offers a novel, promising approach for the treatment of ear keloids. Ablative CO 2 laser therapy is known for its ability to effectively resurface the skin and improve keloid texture by promoting collagen remodeling [2]. In the present study, we meticulously detail our institution's robust clinical experience harnessing this innovative, dual-modality treatment regimen, aiming to meticulously refine ear keloid morphology and enhance its tactile quality.…”
Section: Introductionmentioning
confidence: 99%